1 2 "Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review"
Published 2018-9-7 Endothelial dysfunction and excessively stimulated autophagy, often caused by oxidant injury or inflammation, will lead to atherosclerosis development and progression in diabetes
Impact of obesity on angiogenic and inflammatory markers in the Finnish Genetics of Pre-eclampsia Consortium (FINNPEC) cohort
This article explains: what GLP-1 drugs accomplish what they cannot fix why microbiome repair is essential for long-term results how to build metabolic stability from the inside out If you missed earlier GLP-1 blogs, start here: Microbiome Controls Appetite and Metabolism Natural GLP-1 Support: Fiber, SCFAs, Akkermansia Resetting Metabolism: Microbiome, SCFAs and GLP-1 Frequently Asked Questions GLP-1 Drugs, Microbiome Repair & Long-Term Metabolic Health: 1
Wiviott SD, Raz I, Bonaca MP, Mosenzon O, Kato ET, Cahn A, Silverman MG, Zelniker TA, Kuder JF, Murphy SA, Bhatt DL, Leiter LA, McGuire DK, Wilding JPH, Ruff CT, Gause-Nilsson IAM, Fredriksson M, Johansson PA, Langkilde A-M, DECLARETIMI 58 Investigators (2019) Dapagliflozin and cardiovascular outcomes in type 2 diabetes
